Navigation Links
BioProcessing Solutions Alliance Wins Million Veteran Program Genotyping Contract
Date:11/5/2013

NEW BRUNSWICK, N.J., Nov. 5, 2013 PRNewswire/ -- The U.S. Department of Veterans Affairs has awarded a five-year contract for genotyping in support of its Million Veteran Program to the BioProcessing Solutions Alliance, which is a unique partnership between a research center at Rutgers, The State University of New Jersey, and a corporate provider of sample management solutions for the bioscience industry.

Officials of RUCDR Infinite Biologics, the world's largest university-based biorepository, and BioStorage Technologies, a global corporation providing comprehensive sample management solutions for the bioscience industry, made the announcement today (Nov. 5).

The contract between the VA's Million Veteran Program and the BioProcessing Solutions Alliance provides $7.5 million for year one, with the balance to be determined. It calls for quality control and analysis of 100,000 DNA samples from U.S. military veterans, who have volunteered to participate, from around the country. The Million Veteran Program's purpose is "to better understand how genes affect health and illness in order to improve health care for Veterans," the VA says. The program will construct an extensive database of genetic, military exposure, lifestyle, and health information. Read more here.

Dr. Andrew Brooks, RUCDR's chief operating officer and associate professor of genetics, will serve as principal investigator for the contract.

"We're honored to have been chosen by the Department of Veterans Affairs to perform this critical work on such a valuable research initiative focused on leveraging science to support the health and welfare of the brave men and women who defend our country," Brooks said. "This was the first government opportunity sought by our alliance, and the contract represents a real public-private partnership success."

The BioProcessing Strategic Alliance, launched 14 months ago, has numerous commercial clients, including major pharmaceutical companies.

Greg Swanberg, CEO of BioStorage Technologies, said, "The scientific and technical bioprocessing solutions expertise of RUCDR, combined with BioStorage Technologies leadership in sample management best practices, allow us to deliver a complete and integrated lifecycle solutions approach and enable us to support projects of any size or complexity anywhere in the world."

The BioProcessing Solutions Alliance will utilize Affymetrix' Axiom Genotyping Solution to build a custom microarray tailored to specific genetic and disease-related targets identified by VA scientists and physicians. The billions of high-quality genotypes generated will provide the Million Veteran Program with valuable understanding of how genetic factors affect human health.

"We feel privileged to partner with and serve the BioProcessing Solutions Alliance and Million Veteran Program on this landmark research initiative," said Dr. Frank Witney, president and CEO of Affymetrix. "This partnership reflects our efforts to strengthen our position in the growing translational medicine market and our commitment to work with forward-thinking organizations like the BioProcessing Solutions Alliance and Million Veteran Program team to produce the next generation of biological information that will be beneficial to our veterans' health care."

Formed in 1998, RUCDR Infinite Biologics offers a complete and integrated selection of biological sample processing, analysis, and storage services. The operation is located in four buildings on Rutgers' Busch Campus in Piscataway, N.J., and has more than 120 full-time employees.

The BioProcessing Solutions Alliance between RUCDR and BioStorage Technologies encompasses all biorepository functions, including sample management consulting, study logistics, collection-kit manufacturing, sample storage, tissue collection, and clinical sample bioprocessing, such as blood fractionation, nucleic acid extraction, and cell line establishment. The agreement also covers analytical services, including gene expression, sequencing, and genotyping. RUCDR Infinite Biologics currently stores more than eight million biosamples from researchers around the world, according to Brooks.

"RUCDR was created by scientists for scientists," Brooks said. "We understand the importance of standardization and quality control in a biorepository environment and are expert in marrying technology to specific scientific applications. This provides a real advantage for researchers that engage with us."

RUCDR Infinite Biologics offers a complete and integrated selection of biological sample processing, analysis, and biorepository services to government agencies, academic institutions, foundations, and biotechnology and pharmaceutical companies within the global scientific community. RUCDR Infinite Biologics provides DNA, RNA, and cell lines with clinical data to hundreds of research laboratories for studies on mental health and developmental disorders, drug and alcohol abuse, diabetes, and digestive, liver, and kidney diseases. RUCDR recently received a $44.5 million award from the National Institute of Mental Health to support its NIMH Center for Collaborative Genomics Research on Mental Disorders, which provides services to NIMH-funded scientists engaged in genomic research on mental disorders. The new grant will enable RUCDR to collect, process, and analyze blood and tissue samples from NIMH-funded scientists nationwide and provide advanced statistical and analytic consultation. RUCDR recently completed an $11.4 million expansion and renovation. Learn more at www.rucdr.org.

BioStorage Technologies Inc. is the premier, global provider of comprehensive sample management solutions for the bioscience industry. Offering flexible onsite, offsite and hybrid models for the smartsourcing of research assets, BioStorage Technologies provides a complete life-cycle of sample management solutions. With an expert team of global sample consultants, industry-leading temperature-controlled storage facilities, and state-of-the-art virtual sample management and bioprocessing solutions, the company supports its customers in maximizing opportunities, minimizing risk and reducing costs. BioStorage Technologies, Inc. is a privately held, global corporation.  For more information, visit www.biostorage.com or call +1 866 697 2675 for North America, +49 6155 898 1011 for Europe or +65 31576199 for Singapore or +86 10 8587 2390 for China.Media Contacts:

Edward Tate, 848-445-3153edward.tate@rutgers.eduLisa Gilbert, 317-390-1866lisa.gilbert@biostorage.com  


'/>"/>
SOURCE RUCDR Infinite Biologics
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. The 2013 Bioprocessing Summit to Bring Together International Leaders to Discuss Today's Bioprocess Issues From Cell Line Selection to Manufacturing in Boston, MA
2. Life Technologies Acquires BAC BV, Expands Capabilities in Bioprocessing
3. BioStorage Technologies Expands its Service Offering to Include Advanced Bioprocessing Solutions
4. Extraordinary Shareholders Meeting of Cytos Biotechnology Ltd: Shareholders Approve All Resolutions
5. HighPoint Solutions und InnoPeritus gehen Partnerschaft zum Angebot beispielloser Beratungsdienste auf dem europäischen Life-Sciences-Markt ein
6. Deadline Solutions, Inc. Prepares for a November Launch of Their WVS ® Branded LogTag® Temperature Data Recorder
7. New Fluid Handling Sourcebook from Cole-Parmer Offers Solutions from Lab to Process
8. Pipette.com Launches New Blog Solutions.Pipette.com to Help Scientists Find Liquid Handling Answers
9. Secure Digital Solutions LLC Prepares to Launch New Service - InfoSec Maturity Program Assessment
10. Hastest Solutions, Inc. Announce Their Executive Open House and Ribbon Cutting Event
11. Portal Solutions Launches AuthentiMate™ a “Bring Your Own SharePoint Identity” Solution
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... and LAGUNA HILLS, Calif. , Oct. ... Cancer Research, London (ICR) and University ... SKY92, SkylineDx,s prognostic tool to risk-stratify patients with multiple myeloma ... MUK nine . The University of Leeds ... partly funded by Myeloma UK, and ICR will perform the ...
(Date:10/11/2017)... , ... October 11, 2017 , ... ... (FDA) has granted orphan drug designation to SBT-100, its novel anti-STAT3 (Signal Transducer ... treatment of osteosarcoma. SBT-100 is able to cross the cell membrane and bind ...
(Date:10/10/2017)... ... October 10, 2017 , ... For the second ... a US2020 STEM Mentoring Award. Representatives of the FirstHand program travelled to Washington, ... from US2020. , US2020’s mission is to change the trajectory of STEM education ...
(Date:10/10/2017)... SomaGenics announced the receipt of a Phase ... (Single Cell), expected to be the first commercially available ... from single cells using NGS methods. The NIH,s recent ... development of approaches to analyze the heterogeneity of cell ... for measuring levels of mRNAs in individual cells have ...
Breaking Biology Technology:
(Date:3/30/2017)... March 30, 2017 The research team of ... three-dimensional (3D) fingerprint identification by adopting ground breaking 3D fingerprint minutiae ... realm of speed and accuracy for use in identification, crime investigation, ... cost. ... A research ...
(Date:3/29/2017)...  higi, the health IT company that operates the ... , today announced a Series B investment from ... The new investment and acquisition accelerates higi,s strategy to ... population health activities through the collection and workflow integration ... collects and secures data today on behalf of over ...
(Date:3/27/2017)... 27, 2017  Catholic Health Services (CHS) has ... Society (HIMSS) Analytics for achieving Stage 6 on ... . In addition, CHS previously earned a place ... an electronic medical record (EMR). "HIMSS ... of EMR usage in an outpatient setting.  This ...
Breaking Biology News(10 mins):